Log In
Print this Print this

BGI 002

  Manage Alerts
Collapse Summary General Information
Company Boryung Pharmaceutical Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Gastrointestinal (unspecified)
Indication DetailsImprove digestive function
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today